Concepedia

Quan-Sheng Zhu

QZ

Statistics

Publications

9

Citations

521

H-Index

9

Active since

2003

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Quan-Sheng Zhu is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and cancer cell signaling.

Publications per year

2003–2011

9

Publications

9

Rad51 overexpression contributes to chemoresistance in human soft tissue sarcoma cells: a role for p53/activator protein 2 transcriptional regulation

Jonathan Hannay, Juehui Liu, Quan-Sheng Zhu et al. · Molecular Cancer Therapeutics · 2007 · 133 citations · Full text

Medicine, Molecular Biology, Oncology +17

Dual targeting of AKT and mammalian target of rapamycin: A potential therapeutic approach for malignant peripheral nerve sheath tumor

Changye Zou, Kerrington D. Smith, Quan-Sheng Zhu et al. · Molecular Cancer Therapeutics · 2009 · 86 citations · Full text

Medicine, Oncology, Pharmacology +17

Combining PCI-24781, a Novel Histone Deacetylase Inhibitor, with Chemotherapy for the Treatment of Soft Tissue Sarcoma

Gonzalo Lopez, Juehui Liu, Wenhong Ren et al. · Clinical Cancer Research · 2009 · 78 citations

Medicine, Cancer Biology, Pharmacology +16

G-CSF-induced tyrosine phosphorylation of Gab2 is Lyn kinase dependent and associated with enhanced Akt and differentiative, not proliferative, responses

Quan-Sheng Zhu, Lisa J. Robinson, Vera Roginskaya et al. · Blood · 2003 · 57 citations · Full text

Life Sciences, Biochemistry, Cell Biology +14

Combining EGFR and mTOR Blockade for the Treatment of Epithelioid Sarcoma

Xianbiao Xie, Markus P. Ghadimi, Eric D. Young et al. · Clinical Cancer Research · 2011 · 48 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 9